Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1

Shenghao Li(Hebei Medical University), Xinli Shi(Shanxi University), Qingzhuo Cui(Hebei University of Chinese Medicine), Wenhan Zhou(Hebei University of Chinese Medicine), Yinglin Guo(Hebei University of Chinese Medicine), Liyuan Hao(Chengdu University of Traditional Chinese Medicine), Qing Peng(Peking University), Zhiqin Zhang(Zhongnan Hospital of Wuhan University), Jingmin Ji(Hebei University of Chinese Medicine)
Molecular and Cellular Biochemistry
August 5, 2020
10.1007/s11010-020-03861-0
Cited by 51

Related Papers

Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence
|Cell Death and Differentiation|2016|80
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61
The current status and future of PD-L1 in liver cancer
|Frontiers in Immunology|2023|55
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70
|Phytomedicine|2018|52
Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests
|Clinical Immunology|2022|36